# Chrysalis > ISO 7 and ISO 8 GMP cleanroom hosting for biotech and pharma manufacturing\. Scalable, compliant, and ready when you need them\. Generated by Yoast SEO v28.2, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Our Locations](https://chrysalisgxp.com/our-locations/): Your science, your signature, our space\. In the heart of life sciences hubs\. - [Home Page](https://chrysalisgxp.com/): Launch manufacturing in weeks with flexible GMP suites, in\-house environmental monitoring, warehouse and materials storage, and enterprise IT — all under one roof with no long\-term lock\-ins\. - [What We Offer](https://chrysalisgxp.com/what-we-offer/): Give your innovation a home that gives you the power to control your timelines, resources and risks\. - [Waltham, MA](https://chrysalisgxp.com/our-locations/waltham-ma/): Your GMP cleanroom\. Your pace\. Minutes from Boston’s biotech hub\. - [The Chrysalis Way](https://chrysalisgxp.com/about-us/the-chrysalis-way/): The Chrysalis Way is your way\. Your schedule, your science, our space\. ## CF Leads Tables - [Contact Form Submission](https://chrysalisgxp.com/cfdb_options/contact-form-submission/) ## Articles - [The Hidden Cost of Building: A CFO's Perspective on Why Flexible GMP Infrastructure Often Wins](https://chrysalisgxp.com/news-and-insights/the-hidden-cost-of-building-a-cfos-perspective-on-why-flexible-gmp-infrastructure-often-wins/): Building internal GMP capacity can cost $10 to 13 million more per program than a flexible infrastructure model\. A CFO's look at when the build case works, when it doesn't, and how to allocate capital under real\-world uncertainty\. - [Regulatory and Operational Advantages of a Standardized Manufacturing Network](https://chrysalisgxp.com/news-and-insights/regulatory-and-operational-advantages-of-a-standardized-manufacturing-network/): When transitioning therapies to commercial manufacturing, regulators expect supply continuity and scalable capacity\. Standardized manufacturing networks with identical cleanroom designs and unified quality systems provide regulatory and operational advantages that single\-site facilities cannot match\. - [Frequently Asked Questions About Cleanroom Hosting](https://chrysalisgxp.com/news-and-insights/frequently-asked-questions-about-cleanroom-hosting/): Answers to the most common questions we get about how the Cleanroom Hosting model works, timelines to get started, and who it’s best suited for\. - [FDA Wait Times and Idle Manufacturing Costs: The Case for Flexible GMP Infrastructure](https://chrysalisgxp.com/news-and-insights/fda-wait-times-and-idle-manufacturing-costs-the-case-for-flexible-gmp-infrastructure/): Most biopharma companies focus on getting through FDA review, but few account for what happens to their manufacturing infrastructure during the wait\. With 12\-18 months of regulatory review and additional time for clinical holds, idle facility costs can reach millions\. Cleanroom hosting offers a model where manufacturing capacity flexes with program needs\. - [Environmental Monitoring 101: What Biopharma Innovators Need to Know Before Phase 1](https://chrysalisgxp.com/news-and-insights/environmental-monitoring-101-what-biopharma-innovators-need-to-know-before-phase-1/): Environmental monitoring is critical for Phase 1 manufacturing, and by the time you're ready to start, your EM program should be established, validated, and running smoothly\. ## Team - [Nick Mazzucca](https://chrysalisgxp.com/our-people/nick-mazzucca/): Nick serves as the strategic lead for business development and marketing at Chrysalis where he focuses on identifying growth opportunities, building strategic partnerships, and guiding brand positioning in the highly competitive biotech and pharmaceutical services sector\. His expertise lies in bridging technical solutions with business objectives \- helping clients navigate complex manufacturing challenges while positioning their innovations for success\. Nick holds a Master of Business Administration from Boston College and earned his Bachelor of Science in Biology from Providence College\. - [Sarah Stewart](https://chrysalisgxp.com/our-people/sarah-stewart/): With over 17 years of experience in the pharmaceutical CMO industry, Sarah is an accomplished, results\-driven leader with a deep understanding of drug development, manufacturing operations, and client service excellence\. Her expertise lies in designing and implementing robust program management systems, cultivating long\-term customer partnerships, and ensuring the seamless delivery of complex, projects\. She is known for her strategic mindset, collaborative leadership style, and unwavering commitment to quality and performance\. Sarah holds a Doctor of Philosophy in Pharmaceutical Science from The University of Strathclyde and a Master of Pharmacy from The Robert Gorden University\. - [Sarah Stevens](https://chrysalisgxp.com/our-people/sarah-stevens/): Over the past 20 years, Sarah has held roles spanning from bench scientific and hands\-on GMP operational leadership, through to executive leadership within the CDMO and biopharma service provider space\. Sarah holds a Doctorate of pharmaceutics from the University of Manchester \(Manchester, UK\), as well as a Master of Business Administration and a Master of Pharmacy from the University of Strathclyde \(Glasgow, UK\)\. As the CEO of Chrysalis, Sarah is passionate about providing great customer services in our unique GMP operating environment\. - [James Kalinovich](https://chrysalisgxp.com/our-people/james-kalinovich/): James has a proven track record of success in driving value across a diverse range of industries\. He has extensive experience executing complex capital market transactions exceeding $25 billion, encompassing two successful IPOs, a $6 billion\+ company sale\. James has successfully executed over 30 acquisitions and has implemented organic growth initiatives that have generated over $300 million in EBITDA growth\. James holds an MBA from NYU Stern School of Business and a BS in Accounting from Penn State\. - [Adam Bartley](https://chrysalisgxp.com/our-people/adam-bartley/): Adam leads day\-to\-day operations across Chrysalis’ cleanroom infrastructure, environmental monitoring, and support service teams\. Adam has over 24 years of leadership experience in biopharmaceutical operations\. As a former client, Adam previously partnered with Chrysalis to launch and operate cleanroom\-based manufacturing operations at Editas Medicine\. Adam holds a Bachelor of Science in Biology from Notre Dame College\. ## Services - [Cleanroom Hosting](https://chrysalisgxp.com/what-we-offer/cleanroom-hosting/): Design your space, set your schedule and start manufacturing with a model built entirely around your needs\. - [GMP Warehouse and Material Storage](https://chrysalisgxp.com/what-we-offer/gmp-warehouse-material-storage/): Controlled storage and inventory support to help you stay compliant, organized and in control from start to shipment\. - [GMP Cleaning \& Disinfection](https://chrysalisgxp.com/what-we-offer/gmp-cleaning/): Structured GMP cleaning and disinfection services that support contamination control, deviation response, and inspection readiness\. - [Environmental Monitoring and Testing Services](https://chrysalisgxp.com/what-we-offer/testing-services/): Comprehensive GMP monitoring and testing solutions that keep your cleanroom compliant and under control\. - [Powered by Lead Candidate](https://chrysalisgxp.com/what-we-offer/powered-by-lead-candidate/): Sector\-specific talent to scale your team without slowing your science\. ## Optional - [Sitemap index](https://chrysalisgxp.com/sitemap_index.xml)